Cargando…
Domain-specific interactions between MLN8237 and human serum albumin estimated by STD and WaterLOGSY NMR, ITC, spectroscopic, and docking techniques
Alisertib (MLN8237) is an orally administered inhibitor of Aurora A kinase. This small-molecule inhibitor is under clinical or pre-clinical phase for the treatment of advanced malignancies. The present study provides a detailed characterization of the interaction of MLN8237 with a drug transport pro...
Autores principales: | Yang, Hongqin, Liu, Jiuyang, Huang, Yanmei, Gao, Rui, Tang, Bin, Li, Shanshan, He, Jiawei, Li, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371984/ https://www.ncbi.nlm.nih.gov/pubmed/28358124 http://dx.doi.org/10.1038/srep45514 |
Ejemplares similares
-
Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies
por: Yang, Hongqin, et al.
Publicado: (2017) -
1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery
por: Raingeval, Claire, et al.
Publicado: (2019) -
Protein-ligand binding affinity determination by the waterLOGSY method: An optimised approach considering ligand rebinding
por: Huang, Renjie, et al.
Publicado: (2017) -
NMR WaterLOGSY Reveals Weak Binding of Bisphenol A with Amyloid Fibers of a Conserved 11 Residue Peptide from Androgen Receptor
por: Asencio-Hernández, Julia, et al.
Publicado: (2016) -
MLN8054 and Alisertib (MLN8237): Discovery of Selective
Oral Aurora A Inhibitors
por: Sells, Todd B., et al.
Publicado: (2015)